ClassID:

112288

C12N2830/007 - CPC Classification

Classification description:

Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination

Recent Application in this class:
#1
20250255987
2025-08-14

USE OF ENDOGENOUS ASPARTOACYLASE PROMOTER ELEMENTS FOR TISSUE-RESTRICTED EXPRESSION OF GENE THERAPIES

#2
20250228974
2025-07-17

MODULATION OF NEURAL PATHWAYS

#3
20250205364
2025-06-26

DRUG AND METHOD FOR FORMING GABAERGIC NEURONS

#4
20250043235
2025-02-06

DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION

#5
20240174743
2024-05-30

CHIMERIC OPSIN GPCR PROTEINS

#6
20230220421
2023-07-13

GENE-THERAPY VECTORS FOR TREATING CARDIOMYOPATHY

#7
20230103199
2023-03-30

INTEGRATION OF NUCLEIC ACID CONSTRUCTS INTO EUKARYOTIC CELLS WITH A TRANSPOSASE FROM ORYZIAS

#8
20230042103
2023-02-09

ENGINEERED NUCLEIC ACID REGULATORY ELEMENT AND METHODS OF USES THEREOF

#9
20220411816
2022-12-29

TRANSPOSITION OF NUCLEIC ACID CONSTRUCTS INTO EUKARYOTIC GENOMES WITH A TRANSPOSASE FROM AMYELOIS

#10
20220267801
2022-08-25

ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS

#11
20220162571
2022-05-26

GM3 SYNTHASE VECTORS AND USES THEREOF

#12
20210324408
2021-10-21

Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois

#13
20210292773
2021-09-23

Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias

#14
20210228627
2021-07-29

FUSOSOME COMPOSITIONS AND USES THEREOF

#15
20210139919
2021-05-13

DNA vectors, transposons and transposases for eukaryotic genome modification

#16
20210128750
2021-05-06

Modulation of neural pathways

#17
20200399661
2020-12-24

MATERIALS AND METHODS FOR PREVENTING TRANSMISSION OF A PARTICULAR CHROMOSOME

#18
20200318135
2020-10-08

Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois

#19
20200318121
2020-10-08

Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias

#20
20200190524
2020-06-18

DNA vectors, transposons and transposases for eukaryotic genome modification

#21
20200095609
2020-03-26

Gene-therapy vectors for treating cardiomyopathy

#22
20190338305
2019-11-07

Fertility restoration gene in wheat and uses thereof

#23
20190323018
2019-10-24

DNA Vectors, Transposons And Transposases For Eukaryotic Genome Modification

#24
20190169622
2019-06-06

DNA Vectors, Transposons And Transposases For Eukaryotic Genome Modification

#25
20190160113
2019-05-30

Elimination of proliferating cells from stem cell-derived grafts

#26
20190010505
2019-01-10

DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION

#27
20180312870
2018-11-01

Expression systems

#28
20180271957
2018-09-27

METHODS TO TREAT CEROID LIPOFUSCINOSIS USING A RECOMBINANT ADENO-ASSOCIATED VIRUS

#29
20180271956
2018-09-27

METHODS TO TREAT POMPE DISEASE USING A RECOMBINANT ADENO-ASSOCIATED VIRUS

#30
20180271955
2018-09-27

ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM

#31
20180264090
2018-09-20

ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM

#32
20180258436
2018-09-13

DNA vectors, transposons and transposases for eukaryotic genome modification

#33
20180099030
2018-04-12

Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulfatase using a recombinant adeno-associated virus (AAV) vector encoding iduronate-2-sulfatase

#34
20180036388
2018-02-08

ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM

#35
20180030478
2018-02-01

ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS

#36
20170101647
2017-04-13

DNA vectors, transposons and transposases for eukaryotic genome modification

#37
20170101646
2017-04-13

DNA vectors, transposons and transposases for eukaryotic genome modification

#38
20170101630
2017-04-13

DNA vectors, transposons and transposases for eukaryotic genome modification

#39
20170101629
2017-04-13

DNA vectors, transposons and transposases for eukaryotic genome modification

#40
20160120960
2016-05-05

Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase

#41
20160115458
2016-04-28

TUMOR THERAPY WITH REPLICATION COMPETENT SINDBIS VIRAL VECTORS

#42
20160108430
2016-04-21

Gene-therapy vectors for treating cardiomyopathy

#43
20160060651
2016-03-03

Expression systems

#44
20150072368
2015-03-12

Transcription units and the use thereof in expression vectors

#45
20140141517
2014-05-22

PCP2 mini-promoters

#46
20100197767
2010-08-05

NUCLEIC ACID CONSTRUCT SYSTEMS CAPABLE OF DAIGNOSING OR TREATING A CELL STATE

#47
20090214425
2009-08-27

Tumor therapy with replication competent sindbis viral vectors

#48
20090130061
2009-05-21

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#49
20080171390
2008-07-17

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#50
20080166797
2008-07-10

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#51
20080076173
2008-03-27

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#52
20070244064
2007-10-18

Methods and compositions to induce antitumor response

#53
20070154456
2007-07-05

Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression

#54
20070056051
2007-03-08

Expression system for insect pest control

#55
20060242717
2006-10-26

Expression systems

#56
20060188479
2006-08-24

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#57
20050169890
2005-08-04

Adenovirus vectors containing cell status-specific response elements and methods of use thereof